Unknown

Dataset Information

0

The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension.


ABSTRACT: The HIV-infected population is at a dramatically increased risk of developing pulmonary arterial hypertension (PAH), a devastating and fatal cardiopulmonary disease that is rare amongst the general population. It is increasingly apparent that PAH is a disease with complex and heterogeneous cellular and molecular pathologies, and options for therapeutic intervention are limited, resulting in poor clinical outcomes for affected patients. A number of soluble HIV factors have been implicated in driving the cellular pathologies associated with PAH through perturbations of various signaling and regulatory networks of uninfected bystander cells in the pulmonary vasculature. While these mechanisms are likely numerous and multifaceted, the overlapping features of PAH cellular pathologies and the effects of viral factors on related cell types provide clues as to the potential mechanisms driving HIV-PAH etiology and progression. In this review, we discuss the link between the DNA damage response (DDR) signaling network, chronic HIV infection, and potential contributions to the development of pulmonary arterial hypertension in chronically HIV-infected individuals.

SUBMITTER: Simenauer A 

PROVIDER: S-EPMC7246454 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension.

Simenauer Ari A   Nozik-Grayck Eva E   Cota-Gomez Adela A  

International journal of molecular sciences 20200507 9


The HIV-infected population is at a dramatically increased risk of developing pulmonary arterial hypertension (PAH), a devastating and fatal cardiopulmonary disease that is rare amongst the general population. It is increasingly apparent that PAH is a disease with complex and heterogeneous cellular and molecular pathologies, and options for therapeutic intervention are limited, resulting in poor clinical outcomes for affected patients. A number of soluble HIV factors have been implicated in driv  ...[more]

Similar Datasets

2023-08-15 | GSE215933 | GEO
| S-EPMC10663616 | biostudies-literature
2016-07-15 | E-GEOD-84395 | biostudies-arrayexpress
| S-EPMC3787920 | biostudies-other
| S-EPMC7924564 | biostudies-literature
2003-11-15 | GSE703 | GEO
| S-EPMC3604086 | biostudies-other
2016-07-15 | GSE84395 | GEO
| S-EPMC2894407 | biostudies-literature
| PRJNA891310 | ENA